Cargando…

Increased CD127+ and decreased CD57+ T cell expression levels in HIV-infected patients on NRTI-sparing regimens

BACKGROUND: NRTIs-sparing regimens exert favourable profiles on T-cell homeostasis associated parameters. Our aim was to analyze the effect of NRTIs sparing regimen (NRTI-sparing-cART) vs NRTIs-containing regimen (NRTI-cART), on T-cell homeostasis associated parameters in naive HIV-infected patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonzalez-Serna, A., Ferrando-Martinez, S., Tarancon-Diez, L., De Pablo-Bernal, R. S., Dominguez-Molina, B., Jiménez, J. L., Muñoz-Fernández, M. Á., Leal, M., Ruiz-Mateos, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738860/ https://www.ncbi.nlm.nih.gov/pubmed/29262860 http://dx.doi.org/10.1186/s12967-017-1367-5

Ejemplares similares

Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI
por: Torti, Carlo, et al.
Publicado: (2011)

The state of PI monotherapy and NRTI-sparing therapy
por: Arribas, JR
Publicado: (2010)

Cost-effectiveness of 2NRTI+NNRTI versus 2NRTI+PI as the initial cART regimen
por: Aragão, F, et al.
Publicado: (2010)

Efficacy and safety of an NRTI-sparing regimen in antiretroviral-naïve HIV-infected patients: once-daily maraviroc plus lopinavir/ritonavir
por: Nozza, S, et al.
Publicado: (2010)

Improvement of endothelial function after switching previously treated HIV-infected patients to an NRTI-sparing bitherapy with maraviroc
por: Bernal, Enrique, et al.
Publicado: (2014)

Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy
por: Henrivaux, Philippe, et al.
Publicado: (2010)

Decreased CD127 Expression on CD4+ T-Cells and Elevated Frequencies of CD4+CD25+CD127− T-Cells in Children with Long-Lasting Type 1 Diabetes
por: Moniuszko, Marcin, et al.
Publicado: (2013)

Polyfunctional HIV-1 specific response by CD8+ T lymphocytes expressing high levels of CD300a
por: Vitallé, Joana, et al.
Publicado: (2020)

IL-2 receptor γ chain cytokines differentially regulate human CD8(+)CD127(+) and CD8(+)CD127(−) T cell division and susceptibility to apoptosis
por: Crawley, Angela M., et al.
Publicado: (2009)

The effects of ART on the dynamics of lipid profiles in Chinese Han HIV-infected patients: comparison between NRTI/NNRTI and NRTI/INSTI
por: Liu, Shengnan, et al.
Publicado: (2023)

Progressive Activation of CD127+132− Recent Thymic Emigrants into Terminally Differentiated CD127−132+ T-Cells in HIV-1 Infection
por: Sasson, Sarah C., et al.
Publicado: (2012)

CD4(+)CD25(high)CD127(-) regulatory T-cells in COPD: smoke and drugs effect
por: Chiappori, Alessandra, et al.
Publicado: (2016)

Tag7 (PGLYRP1) Can Induce an Emergence of the CD3+CD4+CD25+CD127+ Cells with Antitumor Activity
por: Sharapova, T. N., et al.
Publicado: (2018)

Development of Immature CD4(+)CD8(+)T Cells Into Mature CD4(+) T Cells Requires Alpha-1 Antitrypsin as Observed by Treatment in HIV-1 Infected and Uninfected Controls
por: Bristow, Cynthia L., et al.
Publicado: (2019)

Altered Expression of CD300a Inhibitory Receptor on CD4+ T Cells From Human Immunodeficiency Virus-1-Infected Patients: Association With Disease Progression Markers
por: Vitallé, Joana, et al.
Publicado: (2018)

HTA and HIV: The Case of Dual NRTI Backbones in the Italian Setting
por: Garagiola, Elisabetta, et al.
Publicado: (2020)

IL‐7 induces sCD127 release and mCD127 downregulation in human CD8(+) T cells by distinct yet overlapping mechanisms, both of which are impaired in HIV infection
por: Côté, Sandra C., et al.
Publicado: (2020)

Detection and Significance of CD4+CD25+CD127dim Regulatory T Cells in Individuals with Severe Aplastic Anemia
por: Qi, Weiwei, et al.
Publicado: (2015)

Increased frequency of CD4(+)CD25(high) CD127(low/)(−) regulatory T cells in patients with multiple sclerosis
por: Khosravi, Maryam, et al.
Publicado: (2019)

CD4(+)CD25(+)CD127(hi) cell frequency predicts disease progression in type 1 diabetes
por: Narsale, Aditi, et al.
Publicado: (2021)

Peripheral CD4(+)CD25(hi)CD127(low) regulatory T cells are increased in patients with gastrointestinal cancer
por: Qiu, Junlan, et al.
Publicado: (2023)

Immune Correlates of Natural HIV Elite Control and Simultaneous HCV Clearance—Supercontrollers
por: Dominguez-Molina, Beatriz, et al.
Publicado: (2018)

CD127+ CD94+ innate lymphoid cells expressing granulysin and perforin are expanded in patients with Crohn’s disease
por: Krabbendam, L., et al.
Publicado: (2021)

Expansion of CD8+CD57+ T Cells in an Immunocompetent Patient with Acute Toxoplasmosis
por: García-Muñoz, R., et al.
Publicado: (2009)

The relationship between CD4(+)CD25(+)CD127(- )regulatory T cells and inflammatory response and outcome during shock states
por: Hein, François, et al.
Publicado: (2010)

CD4(+)CD25(hi)CD127(low) Regulatory T Cells Are Increased in Oral Squamous Cell Carcinoma Patients
por: Lim, Kue Peng, et al.
Publicado: (2014)

CD4 + CD25 + CD127 high cells as a negative predictor of multiple organ failure in acute pancreatitis
por: Wang, Wei, et al.
Publicado: (2017)

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4(+) T reg cells
por: Liu, Weihong, et al.
Publicado: (2006)

Transcriptome analysis reveals similarities between human blood CD3(−) CD56(bright) cells and mouse CD127(+) innate lymphoid cells
por: Allan, David S. J., et al.
Publicado: (2017)

CD4(+)CD25(high)CD127(low/-)FoxP(3)(+) Regulatory T-Cell Population in Acute Leukemias: A Review of the Literature
por: Niedźwiecki, M., et al.
Publicado: (2019)

Expression of PD-1 by CD4(+)CD25(+)CD127(low) Treg cells in the peripheral blood of lung cancer patients
por: Zhong, AnYuan, et al.
Publicado: (2015)

Expression of CD4+CD25+CD127(Low) regulatory T cells and cytokines in peripheral blood of patients with primary liver carcinoma
por: Zhou, Wenchao, et al.
Publicado: (2020)

Increased percentage of T cells with the expression of CD127 and CD132 in hypertrophic adenoid in children with otitis media with effusion
por: Żelazowska-Rutkowska, Beata, et al.
Publicado: (2012)

CD4(+)CD25(+)CD127(−) and CD4(+)CD25(+)Foxp3(+) Regulatory T Cell Subsets in Mediating Autoimmune Reactivity in Systemic Lupus Erythematosus Patients
por: Żabińska, Marcelina, et al.
Publicado: (2016)

Human CD4(+)CD25(+)CD226(-) Tregs Demonstrate Increased Purity, Lineage Stability, and Suppressive Capacity Versus CD4(+)CD25(+)CD127(lo/-) Tregs for Adoptive Cell Therapy
por: Brown, Matthew E., et al.
Publicado: (2022)

Disease Management - Constructing Optimal NRTI-Based Combinations: Past, Present, and Future
por: Dieterich, Douglas T
Publicado: (2006)

Loss of CD127 & increased immunosenescence of T cell subsets in HIV infected individuals
por: Mojumdar, Kamalika, et al.
Publicado: (2011)

Soluble CD127 potentiates IL‐7 activity in vivo in healthy mice
por: Aloufi, Nawaf A., et al.
Publicado: (2021)

CD127 imprints functional heterogeneity to diversify monocyte responses in inflammatory diseases
por: Zhang, Bin, et al.
Publicado: (2022)

Role of CD4(+)CD25(hi)CD127(lo/-)FoxP3(+) regulatory T lymphocytes in the pathogenesis of Behçet’s disease in children
por: Tran, TA, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_b4g83regigisq64iu6fj73fjkb